The Role of Endovascular Stents in Dialysis Access Maintenance

Mohamad El Kassem, Issam Alghamdi, Roberto I Vazquez-Padron, Arif Asif, Oliver Lenz, Tina Sanjar, Fadi Fayad, Loay Salman

Research output: Contribution to journalReview article

11 Citations (Scopus)

Abstract

Vascular stenosis is most often the culprit behind hemodialysis vascular access dysfunction, and although percutaneous transluminal angioplasty remains the gold standard treatment for vascular stenosis, over the past decade the use of stents as a treatment option has been on the rise. Aside from the 2 Food and Drug Administration-approved stent grafts for the treatment of venous graft anastomosis stenosis, use of all other stents in vascular access dysfunction is off-label. Kidney Disease Outcomes Quality Initiative recommends limiting stent use to specific conditions, such as elastic lesions and recurrent stenosis; otherwise, additional adapted indications are in procedure-related complications, such as grade 2 and 3 hematomas. Published reports have shown the potential use of stents in a variety of conditions leading to vascular access dysfunction, such as venous graft anastomosis stenosis, cephalic arch stenosis, central venous stenosis, dialysis access aneurysmal elimination, cardiac implantable electronic device-induced stenosis, and thrombosed arteriovenous grafts. Although further research is needed for many of these conditions, evidence for recommendations has been clear in some; for instance, we know now that stents should be avoided along cannulation sites and should not be used in eliminating dialysis access aneurysms. In this review article, we evaluate the available evidence for the use of stents in each of the aforementioned conditions leading to hemodialysis vascular access dysfunctions.

Original languageEnglish (US)
Pages (from-to)453-458
Number of pages6
JournalAdvances in Chronic Kidney Disease
Volume22
Issue number6
DOIs
StatePublished - 2015

Fingerprint

Stents
Dialysis
Pathologic Constriction
Maintenance
Blood Vessels
Transplants
Renal Dialysis
Kidney Diseases
United States Food and Drug Administration
Angioplasty
Catheterization
Hematoma
Aneurysm
Thrombosis
Therapeutics
Head
Equipment and Supplies
Research

Keywords

  • Aneurysms
  • Cephalic arch stenosis
  • CIED
  • Dialysis access dysfunction
  • Stents

ASJC Scopus subject areas

  • Nephrology

Cite this

The Role of Endovascular Stents in Dialysis Access Maintenance. / El Kassem, Mohamad; Alghamdi, Issam; Vazquez-Padron, Roberto I; Asif, Arif; Lenz, Oliver; Sanjar, Tina; Fayad, Fadi; Salman, Loay.

In: Advances in Chronic Kidney Disease, Vol. 22, No. 6, 2015, p. 453-458.

Research output: Contribution to journalReview article

El Kassem, Mohamad ; Alghamdi, Issam ; Vazquez-Padron, Roberto I ; Asif, Arif ; Lenz, Oliver ; Sanjar, Tina ; Fayad, Fadi ; Salman, Loay. / The Role of Endovascular Stents in Dialysis Access Maintenance. In: Advances in Chronic Kidney Disease. 2015 ; Vol. 22, No. 6. pp. 453-458.
@article{b5da28006b084bba9c9f4ff5f3c86560,
title = "The Role of Endovascular Stents in Dialysis Access Maintenance",
abstract = "Vascular stenosis is most often the culprit behind hemodialysis vascular access dysfunction, and although percutaneous transluminal angioplasty remains the gold standard treatment for vascular stenosis, over the past decade the use of stents as a treatment option has been on the rise. Aside from the 2 Food and Drug Administration-approved stent grafts for the treatment of venous graft anastomosis stenosis, use of all other stents in vascular access dysfunction is off-label. Kidney Disease Outcomes Quality Initiative recommends limiting stent use to specific conditions, such as elastic lesions and recurrent stenosis; otherwise, additional adapted indications are in procedure-related complications, such as grade 2 and 3 hematomas. Published reports have shown the potential use of stents in a variety of conditions leading to vascular access dysfunction, such as venous graft anastomosis stenosis, cephalic arch stenosis, central venous stenosis, dialysis access aneurysmal elimination, cardiac implantable electronic device-induced stenosis, and thrombosed arteriovenous grafts. Although further research is needed for many of these conditions, evidence for recommendations has been clear in some; for instance, we know now that stents should be avoided along cannulation sites and should not be used in eliminating dialysis access aneurysms. In this review article, we evaluate the available evidence for the use of stents in each of the aforementioned conditions leading to hemodialysis vascular access dysfunctions.",
keywords = "Aneurysms, Cephalic arch stenosis, CIED, Dialysis access dysfunction, Stents",
author = "{El Kassem}, Mohamad and Issam Alghamdi and Vazquez-Padron, {Roberto I} and Arif Asif and Oliver Lenz and Tina Sanjar and Fadi Fayad and Loay Salman",
year = "2015",
doi = "10.1053/j.ackd.2015.02.001",
language = "English (US)",
volume = "22",
pages = "453--458",
journal = "Advances in Chronic Kidney Disease",
issn = "1548-5595",
publisher = "W.B. Saunders Ltd",
number = "6",

}

TY - JOUR

T1 - The Role of Endovascular Stents in Dialysis Access Maintenance

AU - El Kassem, Mohamad

AU - Alghamdi, Issam

AU - Vazquez-Padron, Roberto I

AU - Asif, Arif

AU - Lenz, Oliver

AU - Sanjar, Tina

AU - Fayad, Fadi

AU - Salman, Loay

PY - 2015

Y1 - 2015

N2 - Vascular stenosis is most often the culprit behind hemodialysis vascular access dysfunction, and although percutaneous transluminal angioplasty remains the gold standard treatment for vascular stenosis, over the past decade the use of stents as a treatment option has been on the rise. Aside from the 2 Food and Drug Administration-approved stent grafts for the treatment of venous graft anastomosis stenosis, use of all other stents in vascular access dysfunction is off-label. Kidney Disease Outcomes Quality Initiative recommends limiting stent use to specific conditions, such as elastic lesions and recurrent stenosis; otherwise, additional adapted indications are in procedure-related complications, such as grade 2 and 3 hematomas. Published reports have shown the potential use of stents in a variety of conditions leading to vascular access dysfunction, such as venous graft anastomosis stenosis, cephalic arch stenosis, central venous stenosis, dialysis access aneurysmal elimination, cardiac implantable electronic device-induced stenosis, and thrombosed arteriovenous grafts. Although further research is needed for many of these conditions, evidence for recommendations has been clear in some; for instance, we know now that stents should be avoided along cannulation sites and should not be used in eliminating dialysis access aneurysms. In this review article, we evaluate the available evidence for the use of stents in each of the aforementioned conditions leading to hemodialysis vascular access dysfunctions.

AB - Vascular stenosis is most often the culprit behind hemodialysis vascular access dysfunction, and although percutaneous transluminal angioplasty remains the gold standard treatment for vascular stenosis, over the past decade the use of stents as a treatment option has been on the rise. Aside from the 2 Food and Drug Administration-approved stent grafts for the treatment of venous graft anastomosis stenosis, use of all other stents in vascular access dysfunction is off-label. Kidney Disease Outcomes Quality Initiative recommends limiting stent use to specific conditions, such as elastic lesions and recurrent stenosis; otherwise, additional adapted indications are in procedure-related complications, such as grade 2 and 3 hematomas. Published reports have shown the potential use of stents in a variety of conditions leading to vascular access dysfunction, such as venous graft anastomosis stenosis, cephalic arch stenosis, central venous stenosis, dialysis access aneurysmal elimination, cardiac implantable electronic device-induced stenosis, and thrombosed arteriovenous grafts. Although further research is needed for many of these conditions, evidence for recommendations has been clear in some; for instance, we know now that stents should be avoided along cannulation sites and should not be used in eliminating dialysis access aneurysms. In this review article, we evaluate the available evidence for the use of stents in each of the aforementioned conditions leading to hemodialysis vascular access dysfunctions.

KW - Aneurysms

KW - Cephalic arch stenosis

KW - CIED

KW - Dialysis access dysfunction

KW - Stents

UR - http://www.scopus.com/inward/record.url?scp=84983146799&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84983146799&partnerID=8YFLogxK

U2 - 10.1053/j.ackd.2015.02.001

DO - 10.1053/j.ackd.2015.02.001

M3 - Review article

C2 - 26524950

AN - SCOPUS:84983146799

VL - 22

SP - 453

EP - 458

JO - Advances in Chronic Kidney Disease

JF - Advances in Chronic Kidney Disease

SN - 1548-5595

IS - 6

ER -